Figure 1.

Factors impacting early clinical decision-making when managing MDR Gram-negative bacterial infections. Adapted with permission from: Montravers P, Bassetti M. The ideal patient profile for new β-lactam/β-lactamase inhibitors. Curr Opin Infect Dis 2018; 31: 587–93.¹⁹